258 related articles for article (PubMed ID: 33722203)
1. Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre.
Capponi G; Belli G; Giovannini M; Remaschi G; Brambilla A; Vannuccini F; Favilli S; Porcedda G; De Simone L
BMC Cardiovasc Disord; 2021 Mar; 21(1):137. PubMed ID: 33722203
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
[TBL] [Abstract][Full Text] [Related]
3. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
[TBL] [Abstract][Full Text] [Related]
4. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
[TBL] [Abstract][Full Text] [Related]
5. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
Price JF; Kertesz NJ; Snyder CS; Friedman RA; Fenrich AL
J Am Coll Cardiol; 2002 Feb; 39(3):517-20. PubMed ID: 11823091
[TBL] [Abstract][Full Text] [Related]
6. Foetal supraventricular tachycardia treated with sotalol.
Sonesson SE; Fouron JC; Wesslen-Eriksson E; Jaeggi E; Winberg P
Acta Paediatr; 1998 May; 87(5):584-7. PubMed ID: 9641744
[TBL] [Abstract][Full Text] [Related]
7. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
Jouannic JM; Delahaye S; Le Bidois J; Fermont L; Villain E; Dommergues M; Dumez Y
J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
[TBL] [Abstract][Full Text] [Related]
8. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
9. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
Lévy S; Ricard P
Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
[TBL] [Abstract][Full Text] [Related]
10. Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
Dilber E; Mutlu M; Dilber B; Aslan Y; Gedik Y; Celiker A
Pediatr Emerg Care; 2010 Feb; 26(2):82-4. PubMed ID: 20093999
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
[TBL] [Abstract][Full Text] [Related]
12. Safety issues in the treatment of paediatric supraventricular tachycardias.
Pfammatter JP; Bauersfeld U
Drug Saf; 1998 May; 18(5):345-56. PubMed ID: 9589846
[TBL] [Abstract][Full Text] [Related]
13. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy?
Jouannic JM; Delahaye S; Fermont L; Le Bidois J; Villain E; Dumez Y; Dommergues M
Prenat Diagn; 2003 Feb; 23(2):152-6. PubMed ID: 12575024
[TBL] [Abstract][Full Text] [Related]
14. The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
Ergül Y; Özyılmaz İ; Saygı M; Tola HT; Akdeniz C; Tuzcu V
Turk Kardiyol Dern Ars; 2015 Oct; 43(7):607-12. PubMed ID: 26536985
[TBL] [Abstract][Full Text] [Related]
15. Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants?
O'Sullivan JJ; Gardiner HM; Wren C
J Am Coll Cardiol; 1995 Oct; 26(4):991-4. PubMed ID: 7560629
[TBL] [Abstract][Full Text] [Related]
16. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
17. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate.
Ebenroth ES; Cordes TM; Darragh RK
Pediatr Cardiol; 2001; 22(6):483-7. PubMed ID: 11894150
[TBL] [Abstract][Full Text] [Related]
18. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias.
Koyak Z; Kroon B; de Groot JR; Wagenaar LJ; van Dijk AP; Mulder BA; Van Gelder IC; Post MC; Mulder BJ; Bouma BJ
Am J Cardiol; 2013 Nov; 112(9):1461-7. PubMed ID: 23993125
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.
Frohn-Mulder IM; Stewart PA; Witsenburg M; Den Hollander NS; Wladimiroff JW; Hess J
Prenat Diagn; 1995 Dec; 15(13):1297-302. PubMed ID: 8710768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
